List of Studies ( Metabolite:CAR 10:0;OH)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
---|---|---|---|---|---|---|---|
ST003788 | AN006224 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Meningitis | Broad Institute of MIT and Harvard | LC-MS |
ST003788 | AN006224 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis | Broad Institute of MIT and Harvard | LC-MS |
ST003710 | AN006087 | Integrating Metagenomics and Metabolomics to Study the Gut Microbiome and Host Relationships in Sports Across Different Energy Systems | Blood | Human | Universidad del Rosario | LC-MS | |
ST003686 | AN006050 | Characterization of the transpulmonary metabolome at the intersection of pulmonary vascular disease and exercise | Blood | Human | Cardiovascular disease | University of Colorado Anschutz Medical Campus | LC-MS |
ST003587 | AN005891 | Comparison of Machine Learning Models for Metabolomic-Based Clinical Prediction of Preterm Birth | Blood | Human | University of Calgary | LC-MS | |
ST003327 | AN005451 | Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics | Blood | Human | Trauma | University of Colorado Anschutz Medical Campus | LC-MS |
ST002736 | AN004438 | Assessing mitochondrial bioenergetics in coronary artery disease: A translational multiomic tissue study in humans (The AMBITION study). | Heart | Human | Cardiovascular disease | Imperial College London | LC-MS |
ST002727 | AN004421 | Metabolic and Proteomic Divergence is Present in Circulating Monocytes and Tissue Resident Macrophages from Berkeley Sickle Cell Anemia and B-thalassemia mice (Liver) | Macrophages | Mouse | Sickle cell disease | University of Colorado School of Medicine | LC-MS |
ST002726 | AN004419 | Metabolic and Proteomic Divergence is Present in Circulating Monocytes and Tissue Resident Macrophages from Berkeley Sickle Cell Anemia and B-thalassemia mice (Spleen) | Macrophages | Mouse | Sickle cell disease | University of Colorado School of Medicine | LC-MS |
ST002725 | AN004417 | Metabolic and Proteomic Divergence is Present in Circulating Monocytes and Tissue Resident Macrophages from Berkeley Sickle Cell Anemia and B-thalassemia mice (PBMC's) | Mononuclear cells | Mouse | Sickle cell disease | University of Colorado School of Medicine | LC-MS |
ST002694 | AN004367 | MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Untargeted Reversed-Phase Positive | White adipose | Rat | University of Michigan | LC-MS | |
ST002687 | AN004360 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Brown Adipose Powder - Untargeted Reversed-Phase Positive | Brown adipose | Rat | University of Michigan | LC-MS | |
ST002681 | AN004353 | Non-T2D vs T2D | Blood | Human | Diabetes | University of Colorado Anschutz Medical Campus | LC-MS |
ST002680 | AN004352 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Untargeted Reversed-Phase Positive | Liver | Rat | University of Michigan | LC-MS | |
ST002673 | AN004345 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Lung Powder - Untargeted Reversed-Phase Positive | Lung | Rat | University of Michigan | LC-MS | |
ST002658 | AN004330 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Reversed-Phase Positive | Kidney | Rat | University of Michigan | LC-MS | |
ST002653 | AN004325 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Reversed-Phase Positive | Heart | Rat | University of Michigan | LC-MS | |
ST002652 | AN004324 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Lipidomics, Reversed-Phase Positive | Heart | Rat | Georgia Institute of Technology | LC-MS | |
ST002647 | AN004319 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Untargeted Reversed-Phase Positive | Gastrocnemius | Rat | University of Michigan | LC-MS | |
ST002639 | AN004311 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Reversed-Phase Positive | Hippocampus | Rat | University of Michigan | LC-MS | |
ST002631 | AN004303 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Untargeted Lipidomics, Reversed-Phase Positive | Blood | Rat | Georgia Institute of Technology | LC-MS | |
ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
ST002184 | AN003577 | Metabolic effect of the loss of mitochondrial-specific aspartyl-tRNA synthetase Das2 on mouse intestinal epithelial cells | Intestine | Mouse | CECAD Research Center | LC-MS | |
ST002058 | AN003350 | Muscle/Lung/Tumor metabolomics | Lung | Mouse | Cancer | University of Colorado Anschutz Medical Campus | LC-MS |
ST002058 | AN003350 | Muscle/Lung/Tumor metabolomics | Muscle | Mouse | Cancer | University of Colorado Anschutz Medical Campus | LC-MS |
ST002041 | AN003321 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Spleen) | Spleen | Mouse | University of Colorado Anschutz Medical Campus | LC-MS | |
ST002040 | AN003319 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Colon) | Colon | Mouse | University of Colorado Anschutz Medical Campus | LC-MS | |
ST001332 | AN002221 | LCMS lipid and acyl-carnitine analysis | Worms | C. elegans | Environmental exposure | University of Cambridge | LC-MS |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS |